Aztreonam-d6

• CAT Number: S000471
• CAS Number: 1127452-94-1
• Molecular Formula: C13H11D6N5O8S2
• Molecular Weight: 441.47
• Purity: ≥95%
• IUPAC Name: 2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3,3,3-trideuterio-2-(trideuteriomethyl)propanoic acid
• InChI: InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1/i2D3,3D3
• InChIKey: WZPBZJONDBGPKJ-XFXAWXATSA-N
• SMILES: CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N

Aztreonam-d6（Cat No.:S000471） is a deuterated variant of aztreonam, where six hydrogen atoms are replaced with deuterium, enhancing its metabolic stability and altering pharmacokinetics for research purposes. Aztreonam is a synthetic monocyclic beta-lactam antibiotic, specifically a monobactam, primarily used to treat infections caused by gram-negative bacteria. It functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The deuterated version, aztreonam-d6, allows researchers to study the detailed metabolic pathways and degradation processes of the drug, providing insights that can help in developing more effective treatments.